Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Exploring the role of the transcription factor E26 transformation-specific-related gene (ERG) as a gatekeeper of endothelial cell identity and function in the context of atherosclerosis
FY 2023-24
Summary
Atherosclerosis is a common life-long disease that results in significant death world-wide. Risk factors such as high blood pressure, smoking, and high cholesterol contribute to atherosclerosis, leading to plaque build-up in arteries over the course of decades. Plaque, made up of fat, cells, and other components, continues to grow with disease progression, ultimately blocking blood flow or rupturing, resulting in devastating consequences such as heart attack and stroke. Inflammation of the cells that line blood vessels (endothelial cells; ECs) is a key event in atherosclerosis and many of the risk factors for this disease results in vascular inflammation. E-26 transformation specific-related gene (ERG) is a key regulatory protein that promotes EC health and function by maintaining low levels of inflammation in the blood vessel wall. Our study seeks to investigate how ERG controls healthy EC function, and how this might be disrupted in atherosclerosis via two main aims. Aim 1 is to establish how loss of ERG in ECs might lead to dysfunction that could then contribute to atherosclerosis. We will investigate how ERG loss might result in fat and other cellular component buildup - both key contributors to plaque development. Aim 2 will seek to restore EC function by modulating proteins that are altered by ERG loss. These experiments will provide important findings for future studies that will investigate the treatment of atherosclerosis in animal models. By identifying how ERG promotes EC health and function and how this might be disrupted in atherosclerosis, we will identify therapeutic targets that could be used to prevent atherosclerosis and related health effects in patients.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506276
Name
Schulz Kristen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the role of the transcription factor E26 transformation-specific-related gene (ERG) as a gatekeeper of endothelial cell identity and function in the context of atherosclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atherosclerosis; Cardiovascular Disease; Endothelial Cell Biology; Endothelial Cell Identity; Endothelial To Mesenchymal Transition; Erg; Inflammation; Vascular Health
Abstract
Atherosclerosis is a common life-long disease that results in significant death world-wide. Risk factors such as high blood pressure, smoking, and high cholesterol contribute to atherosclerosis, leading to plaque build-up in arteries over the course of decades. Plaque, made up of fat, cells, and other components, continues to grow with disease progression, ultimately blocking blood flow or rupturing, resulting in devastating consequences such as heart attack and stroke. Inflammation of the cells that line blood vessels (endothelial cells; ECs) is a key event in atherosclerosis and many of the risk factors for this disease results in vascular inflammation. E-26 transformation specific-related gene (ERG) is a key regulatory protein that promotes EC health and function by maintaining low levels of inflammation in the blood vessel wall. Our study seeks to investigate how ERG controls healthy EC function, and how this might be disrupted in atherosclerosis via two main aims. Aim 1 is to establish how loss of ERG in ECs might lead to dysfunction that could then contribute to atherosclerosis. We will investigate how ERG loss might result in fat and other cellular component buildup - both key contributors to plaque development. Aim 2 will seek to restore EC function by modulating proteins that are altered by ERG loss. These experiments will provide important findings for future studies that will investigate the treatment of atherosclerosis in animal models. By identifying how ERG promotes EC health and function and how this might be disrupted in atherosclerosis, we will identify therapeutic targets that could be used to prevent atherosclerosis and related health effects in patients.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Schulz, Kristen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~